Clinical trial
Investigation of Incidence Rate of Post-stroke Seizure and Post-stroke Epilepsy in Patients Under Treatment With Alteplase and Correlated Factors
NCT06812000 is registered in ClinicalTrials.gov with Mazandaran University of Medical Sciences as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Investigation of Incidence Rate of Post-stroke Seizure and Post-stroke Epilepsy in Patients Under Treatment With Alteplase and Correlated Factors
- Lead sponsor
- Mazandaran University of Medical Sciences
- Phase
- Observational
- Overall status
- Completed
- Start date
- April 14, 2024
- Completion date
- January 12, 2025
- Enrollment
- 199 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
post-stroke epilepsy, post-stroke seizure, thrombolytic (t-pa) treatment